Our Research Center, with Crestovo (a pharmaceutical company), is seeking volunteers to participate in a clinical research study to prevent recurrent Clostridium difficile (C. difficile).
To be eligible for the study, you must be:
All Study visits will be performed and Investigational medication and procedures will be provided at no charge to you.
This trial is conducted under a US Food and Drug Administration Investigational New Drug Application.
Why is the ECOSPOR III study Important?
The leading risk factor for Clostridium difficile infection (CDI) is a prior history of taking antibiotics. Exposure to antibiotics can harm the good bacteria in the gut that make up our microbiome. These beneficial bacteria protect us from harmful invaders, like C. difficile, which can cause diarrhea. Although CDI treatment is available, many patients continue to have recurrent infections because their microbiome doesn't recover.
To qualify for this study, a person must:
All study-related visits, tests, and medication will be provided to participants at no cost. Reimbursement for time and travel may be provided.
If you have Crohn's consider taking part in the Etro Study.
WHY PARTICIPATE IN A CLINCIAL TRIAL?
You may get expert medical care from leading specialists and nurses throughout the study
You remain in control of your level of participation
You contribute to scientific understanding of Crohn's
Help us open the door to a potential new treatment option for patients with Crohn's disease.
If you have Crohn's disease, you may be able to join a new research study. Will you help us?
Are you living with Crohn's disease (CD)? We are looking for patients with CD to take part in a research study caaled VOLTAIRE-CD. The VOLTAIRE Study is looking at how safe and effective an investigational medication is when given to patients with CD.
You may be able to take part in this study if you, at a minimun:
* are 18-80 years of age
* were diagnosed more than 4 months ago with moderate to severe CD and still sometimes have flares.
Please contact us if you think you may be able to take part in, or if you are interested in learning more about, the VOLTAIRE-CD Study. We will be happy to answer any questions that you may have.
We are currently conducting a study for patients with NonAlcoholic Fatty Liver Disease (NASH). If you are between the ages of 18 and 70 and have NASH or NAFLD (Nonalcoholic fatty liver disease) you may be eligible for this study.
Do you have Chronic Pancreatitis?
If you are eligible for this study, you will recieve the following at no cost to yourself: